DeLong Mark Jeffrey

Apellis Pharmaceuticals, Inc. · Chief Business & Strat Officer

DeLong Mark Jeffrey is listed in public filings as officer: Chief Business & Strat Officer. This DeLong Mark Jeffrey insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Apellis Pharmaceuticals, Inc. (APLS). Investors use DeLong Mark Jeffrey's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Apellis Pharmaceuticals, Inc.APLS$73k3.4k sharesSellJan 22, 2026$21.77--
Apellis Pharmaceuticals, Inc.APLS$26k1.3k sharesSellJan 20, 2026$19.79--
Apellis Pharmaceuticals, Inc.APLS$39k1.8k sharesSellJan 13, 2026$22.19--
DeLong Mark Jeffrey History Trades | TradingNote